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Electrical activity in the heart exhibits 24-hour rhythmicity, and potentially fatal arrhythmias
are more likely to occur at specific times of day. Here, we demonstrate that circadian clocks
within the brain and heart set daily rhythms in sinoatrial (SA) and atrioventricular (AV) node
activity, and impose a time-of–day dependent susceptibility to ventricular arrhythmia. Criti-
cally, the balance of circadian inputs from the autonomic nervous system and cardiomyocyte
clock to the SA and AV nodes differ, and this renders the cardiac conduction system sensitive
to decoupling during abrupt shifts in behavioural routine and sleep-wake timing. Our findings
reveal a functional segregation of circadian control across the heart’s conduction system and
inherent susceptibility to arrhythmia.
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Pronounced time-of-day variation exists in most aspects of ourcardiovascular physiology. This includes cardiac electro-physiology, where daily rhythms in heart rate (HR) and
electrocardiogram (ECG) parameters can be readily observed in
humans and laboratory animals1. Importantly, these temporal
dynamics are not simply a consequence of the sleep–wake cycle or
activity state, but are also heavily influenced by the body’s internal
circadian clock2–4. The circadian system is orchestrated by a master
clock, located in the suprachiasmatic nuclei (SCN) of the hypo-
thalamus, which directs gross rhythms in our physiology (e.g., daily
sleep/wake, hormone, and temperature cycles) and keeps us aligned
with the external light/dark environment. Circadian clocks also
operate in most cells of the body. Therefore, daily fluctuation in
tissue function reflects not only our behavioral state but also the
activity of both central and local circadian clock function. As a
prime example, the SCN contribute to rhythms in HR and heart
rate variability (HRV) across the day via the autonomic nervous
system5,6, yet many aspects of cardiac function including con-
tractility, metabolism, and even recovery from ischemic insult are
strongly influenced by the local cardiomyocyte clock3,4,7,8.
The time-of-day prevalence in many life-threatening cardiac
rhythm disorders (e.g., extreme bradycardia, ventricular fibrillation,
tachycardia, and sudden cardiac death) is well-documented1.
Genetic disruption of clock function selectively in cardiomyocytes
in mice can slow HR7, lengthen QT interval4, and alters ventricular
expression of a number of ion channels responsible for electrical
conduction in the heart (e.g., Scn5a, Kcnh2)4,9,10. Circadian mis-
alignment can occur when our daily behavioral routine and/or
external environment does not match our internal clock timing. We
have recently shown that circadian misalignment driven by altered
environmental light/dark cycles or imposed behavioral routine leads
to altered cardiac electrophysiology in mice11 and humans12. A role
for the cardiomyocyte clock in cardiac arrhythmogenesis has also
been previously implied, but never directly demonstrated10. Despite
these findings, the source and mechanism of circadian control over
the cardiac conduction system, and especially at the level of
sinoatrial (SA) and atrioventricular (AV) function remain unclear.
This is an important issue as conditions that disrupt our circadian
system, such as shift work, are associated with increased incidence
of cardiovascular events including conduction disorders3,13–15.
Long-term continuous ECG recording and analyses provide a
powerful and non-invasive method for determining cardiac
conduction dynamics across time and in response to environ-
mental or behavioral manipulations. Changes in HR and HRV
have been associated with increased cardiovascular risk in
numerous clinical conditions and in healthy individuals16,17.
Beyond HR and HRV, ECG waveforms reveal underlying activity
at the SA node (RR), atrial depolarization (Pwave), conduction
delay at the AV node (PRsegment), ventricular depolarization
(QRS), and ventricular repolarization time (QT) (Supplementary
Fig. 1). Each of these parameters has important diagnostic value,
and alterations therein are associated with an increased risk of
potentially fatal conduction disturbance such as heart block
(prolonged PR interval18) and sudden cardiac death (long QT19).
In this work, we investigate temporal aspects of cardiac electro-
physiology in mice and humans, under normal conditions and in
response to imposed shifts in behavioral routine (i.e., timing of
sleep, activity, feeding, and ambient light exposure). These studies
reveal distinct circadian and behavioral influence over aspects of
cardiac function, as well as a pronounced impact of time-of-day and
circadian clock function on susceptibility to cardiac arrhythmias.
Results
Mistimed sleep and behavioral cycles disrupt rhythms in SA
and AV node activity in humans. We first defined the influence
of abrupt changes in the daily behavioral routine on cardiac
electrophysiology using ECG recordings collected during our
previous human sleep studies20,21. First, continuous ECG
recordings were obtained from 25 healthy men (11 experienced
shift workers, 14 age-matched controls) over a 4-day in-labora-
tory study20. Following 24 h of baseline recording, subjects
underwent one night of total sleep deprivation (TSD), with a 4-h
recovery nap the following afternoon (Fig. 1A). All participants
remained in a semi-recumbent position during sleep episodes and
equivalent waking periods on baseline and TSD days. HR and
ECG characteristics were extracted and analyzed across the entire
study. Robust diurnal rhythms in HR and many ECG char-
acteristics (HRV, RR, QT, PRseg intervals) were observed in both
control (Fig. 1B–F and Supplementary Fig. 2) and shift workers
(Supplementary Fig. 3) under baseline conditions (black traces).
ECG characteristics did not differ significantly between shift-
work and control groups in terms of either 24 h mean or
rhythmic profile at baseline (Supplementary Table 1).
In control (non-shift-work) individuals, TSD and subsequent
daytime recovery nap led to an expected and significant response
in HR and RR interval during TSD and recovery nap, compared to
equivalent times on the baseline day (Fig. 1B, D and Supplemen-
tary Fig. 2). QT interval is strongly influenced by HR, and as such
mirrored the changes in RR (Fig. 1E and Supplementary Fig. 2).
By contrast, PRseg duration (reflecting conduction through the AV
node) was insensitive to the change in behavioral state, and
followed a consistent 24 h profile across baseline and TSD days
(Fig. 1F and Supplementary Fig. 2). While we have previously
reported a small difference in RR variability (SDNN) following
sleep deprivation20, no differences in HRV were found between
baseline and TSD days using a geometric measure22 which is
robust against changes in absolute HR (Fig. 1C). This suggests that
time-of-day variation in parasympathetic tone (thought to be
largely responsible for the circadian rhythm in HRV6) was not
disturbed by the change in arousal state. Thus, two critical aspects
of cardiac conduction, SA node pacemaking, and AV nodal delay
(reflected by RR and PRseg duration, respectively) exhibit clear and
robust daily rhythms, yet are differentially responsive to altered
sleep/wake and behavioral state. Given this temporal discordance,
we next defined the interdependence of RR and PRseg measures
over long (24 h) and short (5 min) time intervals (Fig. 1G–I). As
expected, RR and QT interval profiles were closely aligned across
the day. By contrast, the diurnal profile of PRseg was offset (phase
delayed) from that of RR interval under normal (baseline)
conditions (Fig. 1G), as confirmed by cross-correlation analyses
(Fig. 1H). The relative insensitivity of PRseg to changes in RR was
also evident over short timescales, where acute changes in RR
interval between consecutive 5-min analytical bins were accom-
panied by a concordant change in QT interval, but not in PRseg
(Fig. 1I). The insensitivity of PRseg duration to TSD and recovery
nap, the phase offset between rhythms in RR and PRseg, and the
insensitivity of PRseg to acute changes in RR were all similarly
observed in the experienced shift workers (Supplementary Fig. 3).
Together, these findings reveal a pronounced difference in the
regulation of SA and AV nodal function and in their response to
acute shifts in behavioral routine.
We next investigated the impact of a simulated shift-work
routine on cardiac electrophysiology in a second in-laboratory
study (Fig. 2A–C and Supplementary Table 212,21). Here, healthy
individuals were assigned to either a day-shift or night-shift
routine (n= 7/condition). As in the first study, diurnal rhythms
in RR, QT, and PRseg intervals were evident under baseline
conditions and maintained throughout the study in day-shift
individuals (Fig. 2B). Following baseline ECG recording, the
behavioral cycles of the night-shift group were reversed, and day/
night differences in RR and QT intervals rapidly adjusted to the
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newly imposed schedule. By contrast, the daily rhythm in PRseg
did not adapt to the night-shift routine throughout the study
(Fig. 2C). This lack of rapid adaptation in the PRseg rhythm is
consistent with slow circadian re-entrainment after an abrupt
behavioral phase shift. Immediately following the 4-day-shift
routine, all participants were placed under a constant routine
protocol—a gold-standard procedure that removes or holds
constant external timing influences (through constant dim light
fixed ambient temperature, hourly isocaloric snacks) and
behavioral rhythms (through constant semi-recumbent posture,
no sleep) to reveal circadian clock-controlled processes. Indeed,
RR, QT, and PRseg parameters exhibited circadian rhythmicity
under constant routine in both day- and night-shift groups
(Fig. 2D–F). Rhythms in RR, QT, and PRseg exhibited a similar
phase (i.e., time of peak interval duration) between day- and
night-shift groups when aligned to external clock time (but not
when aligned to time awake). This suggests that the circadian
mechanism that underpins ECG rhythmicity is robust against
acute change in behavioral patterns, and opposes the more direct
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Fig. 1 Longitudinal ECG reveals differential circadian regulation of sinoatrial (SA) and atrioventricular (AV) node function and decoupling by mistimed
sleep. A. Schematic of 4-day laboratory session20, with total sleep deprivation (TSD) and recovery nap on day 3 (n= 14 individuals). B–F HR (B), HRV (C),
and z-scored ECG parameter profiles under baseline (black) and TSD (orange) days (shading indicates+ /−SEM), highlighting the profound impact of
mistimed sleep on RR (D) and QT (E), but not PRseg (F). HR has been derived from the RR interval and is shown for clarity. At baseline, all parameters were
rhythmic based on cosinor analysis (P < 0.001). Individual traces were excluded from waveform analysis where data coverage fell <70% of the 5-min time
bins; n (baseline/TSD)= 13/14 (B), 12/14 (C), 13/14 (D), 11/12 (E), 12/14 (F). Mean ECG parameters were quantified across a 4 h mid-night and mid-day
(equivalent to the nap window on day 3) analysis windows on the baseline and TSD days (two-way RM ANOVA/Mixed model; n= 14 (B, C, D, F), 12 (E)).
G, H Under baseline conditions, LOWESS fit of ECG profiles (G) and cross-correlation (H; yellow: RR vs RR, blue: QT vs RR, orange: PRseg vs RR) revealed a
significant phase delay in PRseg rhythm relative to that of RR (Gaussian fit with one-sample T test; n= 13, 11, 12, respectively). I Acute changes in RR were
mirrored by a concordant change in QT, but not PRseg duration (ΔRR reflects z-scored difference in RR between sequential 5-min analysis bins; Δparam
reflects the concurrent change in QT or PR). All data presented as group mean ± SEM; ns P > 0.05, **P < 0.01, ***P < 0.001. bpm= beats per minute; std=
standard deviation. See Supplementary Fig. S2 for additional information; source data and statistical details are provided as a Source Data File.
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Thus, two independent human studies clearly reveal circadian
rhythmicity in chronotropic and dromotropic properties of the
heart. However, these inputs are not equal at the SA and AV
nodes. Moreover, while the SA node is also heavily influenced by
acute alterations in behavior, the AV node is robust against such
changes.
Differential circadian characteristics of SA and AV node
activity are consistent between mice and humans. To gain
mechanistic insight into where and how circadian control is
exerted over cardiac electrophysiology and whether it contributes
to arrhythmia susceptibility, we turned to murine models. Wild-
type mice studied under a 12-h light, 12-h dark (LD) cycle exhibit
robust daily rhythms in HR, HRV, and ECG characteristics,
including RR, QT, and PRseg intervals (Fig. 3A and Supplemen-
tary Fig. 4). Importantly, analysis of ECG rhythmicity in mice
revealed striking similarity to the human findings detailed above,
despite mice being nocturnal. Mice commonly exhibit a bout of
decreased locomotor activity (and concurrent increase in
sleep) in late-night (Fig. 3A, arrow)23. This “siesta” period was
accompanied by a significant decrease in HR, and lengthening of
RR and QT intervals; however, parallel changes in PRseg duration
were not evident (Fig. 3A, B and Supplementary Fig. 4B). This is
akin to the response to daytime nap in human studies. To
examine more directly the impact of locomotor activity on ECG
parameters, we identified recording intervals showing increased
activity which were then followed by >45 min of continuous
inactivity (Fig. 3C). These analyses revealed a significant influence
of locomotor activity on RR and QT intervals (as expected), and a
much smaller yet still significant response in PRseg duration.
Nevertheless, for all three parameters, this direct impact of
activity cannot account fully for their normal diurnal variation
(~2 SD from peak to trough). Isolation of sporadic activity bouts
(bouts of locomotor activity within a 5-min analysis bin both
preceded and followed by inactivity) revealed a significant
response in RR and QT intervals but not in PRseg (Fig. 3D).
Similar to observations in the human studies, acute changes in RR
interval (between 5-min analysis windows) were reflected in
concordant responses in QT, but not of PRseg (Fig. 3E). Thus, in
mice, like humans, PRseg duration exhibits a robust daily rhythm
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Fig. 2 ECG response under simulated night-shift and constant routine. A Schematic of 6-day laboratory session with simulated day-shift (left) and night-
shift (right) routines (n= 7 individuals/group21). B, C ECG parameters recorded during mid-day (pink) and mid-night (green) showed a rapid reversal of RR
and QT interval rhythms, but not that of PRseg in response to the switch to night-shift behavioral routine. Two-way ANOVA with repeated measures,
colored asterisks indicate the difference from day 1. D Hourly binned z-scored group data and sinusoid fits from day- (orange) and night-shift (blue)
conditions. Data presented as group mean ± SEM. E, F Timing (acrophase) of individual rhythm peaks relative to lights on (i.e., start of constant routine)
(E) or external clock time (F). Asterisks indicate differences between groups (Watson–Williams test). *P < 0.05, **P < 0.01, ***P < 0.001. Source data and
statistical details are provided as a Source Data File.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22788-8
4 NATURE COMMUNICATIONS | (2021) 12:2472 | https://doi.org/10.1038/s41467-021-22788-8 | www.nature.com/naturecommunications
We next assessed the impact of an acute phase shift of the LD
cycle in mice, thereby mimicking the mistimed sleep and
simulated shift-work studies in humans. Here, mice were exposed
to an abrupt 9 h advance in the LD cycle (Fig. 3F). This caused a
rapid adjustment of the RR interval rhythm to the new timing
(Fig. 3G, H). By contrast, rhythms in PRseg were much slower to
adapt, leading to a temporary misalignment of RR and PRseg
interval rhythms within individual mice (Fig. 3G) and across the
population mean (Fig. 3H, I). As evident in the body temperature
profile (Fig. 3F), the central circadian clock shows slow gradual
adaption to the new LD schedule. That body temperature and
PRseg interval rhythms exhibit similar shift dynamics (Supple-
mentary Fig. 4) suggests that the AV node is similarly influenced
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being night or day active (respectively), circadian control of the
SA and AV nodes is strikingly similar.
The source of circadian control at the SA and AV nodes
remains unclear, although both temporal variations in autonomic
nervous system input and the local cardiomyocyte clock have
been implicated in daily rhythms in cardiac function3. To
discriminate these rhythmic influences, we undertook a sequen-
tial pharmacological blockade of sympathetic and parasympa-
thetic branches of autonomic input using metoprolol and
atropine (respectively). Autonomic blockade in conscious free-
moving mice was confirmed by a pronounced reduction in HRV
(Fig. 4A). The sympathetic blockade caused an expected
lengthening of RR interval at the beginning of the animals’
active phase (zeitgeber time 12; ZT12), yet significant time-of-day
differences remained in RR, QT, and PRseg intervals. However,
the diurnal variation in PRseg was lost upon complete autonomic
blockade (Fig. 4B), strongly suggesting that daily rhythms in AV
node conduction delay are dictated by circadian input via the
parasympathetic branch of the autonomic nervous system.
By contrast to PRseg, significant time-of-day differences in RR
and QT intervals were maintained under complete autonomic
blockade (reflecting intrinsic HR; Fig. 4B). This reveals a role for a
local cardiac clock in setting HR rhythms across the day. To test this
directly, we generated a mouse line with Bmal1 (essential for
circadian clock function) deleted selectively in cardiomyocytes
(αMHCCREBmal1Fl/Fl). Although RR and QT intervals are
lengthened overall in these mice7,9, robust daily rhythms in RR,
QT, and PRseg are maintained (Supplementary Fig. 5). Importantly,
complete autonomic blockade eliminated time-of-day differences in
RR and QT intervals in the αMHCCREBmal1Fl/Fl but not littermate
control mice, confirming that the cardiac clock contributes to
setting 24-h rhythms in these parameters (Fig. 4C). To highlight the
relative influence of the cardiomyocyte clock over HR, we plotted
RR interval distribution across 24 h in control (Bmal1Fl/Fl) and
αMHCCREBmal1Fl/Fl mice (Fig. 4D). These plots suggest that local
cardiac clock activity confers a time-of-day-dependent rhythm in
excitability within the SA node, onto which sympathetic and
parasympathetic regulation is imposed. Indeed, microdissection of
the SA node across 24 h revealed not only robust clock function in
this site, but also the rhythmic expression of influential ion channels
and related factors (Supplementary Fig. 6). The influence of Bmal1
over SA node pacing and ion channel expression has also recently
been reported by another group, supporting an important role for
the local clock in SA node function24. Comparison between the two
genotypes also suggests that the cardiomyocyte clock modulates
sensitivity to parasympathetic input at specific times of day, due to
the increased prevalence of low HR across the day and late-night
(Fig. 4D).
The cardiomyocyte clock dictates a heart-intrinsic time-of-day
vulnerability to ventricular arrhythmia. To remove all systemic
cues, we next recorded electrical activity directly from the
atrial and ventricular myocardium of Langendorff-perfused
αMHCCREBmal1Fl/Fl and control hearts. Similar to in vivo auto-
nomic blockade studies, control hearts displayed a robust time-of-
day difference in RR interval that was abolished in hearts lacking
a functional cardiomyocyte clock (Fig. 5A). No time-of-day dif-
ference was observed in atrial to ventricular delay (time between
atrial and ventricular action potentials, akin to PRseg) in control
or αMHCCREBmal1Fl/Fl hearts, confirming in vivo observations
(Fig. 5B). This cardiomyocyte clock-governed variation in HR
implies a daily variation in pacemaker cell excitability, supported
by rhythmic ion channel expression in the SA node (Supple-
mentary Fig. 6).
To examine more generally the potential contribution of the
clock to cardiomyocyte excitability, we recorded spontaneous
firing in isolated neonatal cardiomyocytes. This revealed a
pronounced circadian rhythm in spontaneous firing frequency,
with firing rhythms aligning to cell-inherent oscillations in the
clock protein PERIOD2 (measured by PER2::LUC biolumines-
cence in parallel cardiomyocyte cultures) (Fig. 5C–E). This
suggests that the propensity of pacemaker cardiomyocytes to
spontaneously depolarize and fire action potentials varies across
the day and that this temporal pattern is driven by a local cellular
circadian clock.
Given this intrinsic time-of-day rhythm in cardiomyocyte
excitability, we next investigated the susceptibility to induced
arrhythmia via direct electrical stimulation in the perfused heart
preparation. A strong diurnal variation in susceptibility to
ventricular tachycardia (VT) was observed in hearts isolated
from control animals (Fig. 5F, G). Increased propensity to
arrhythmia was observed at ZT12, which is the beginning of the
animals’ active phase, similar to the early morning peak in the
occurrence of sudden cardiac death in humans25. Remarkably,
time-of-day variation in susceptibility to arrhythmia was not
evident in αMHCCREBmal1Fl/Fl hearts, with these hearts being
resistant to electrically induced VT. Thus, the cell-autonomous
propensity for electrical firing is governed by the cardiomyocyte
circadian clock, and this inherent rhythmicity is associated with
time-of-day susceptibility to ventricular arrhythmias.
To confirm these findings in vivo and specifically interrogate
vulnerability to adrenergic challenge, we employed an established
method for catecholamine-induced arrhythmogenesis. As pre-
viously reported26,27, wild-type mice are relatively insensitive to
the administration of caffeine and adrenaline, whereas
arrhythmia-prone mice, such as those carrying mutation or
deletion of the ryanodine receptor (Ryr2) or calsequestrin (Casq2)
Fig. 3 Longitudinal ECG recording reveals differential circadian regulation of SA and AV node function in mice. A Rhythms in locomotor activity (LA,
arbitrary units) and ECG-derived heart rate (HR), HRV, RR, QT, and PRseg parameters in mice (based on 5 days of recording; shading reflects+ /− SEM; x
axis black bar indicates dark phase; n= 10 mice). B–E Impact of LA and HR on ECG parameters. B Decreased LA during mid-night siesta (marked by an
arrow in A) was accompanied by a significant decrease in RR and QT intervals, but not in PRseg duration (2-h siesta period (black) vs preceding 2 h of
activity (blue); two-way RM ANOVA). C Periods of LA followed by >45min of complete inactivity were isolated and aligned to the cessation of activity
(time 0). RR (yellow), QT (blue), and to a lesser extent PRseg (orange) showed a significant response to the activity which decreased over subsequent
inactivity (two-way RM ANOVA, Dunnet’s post hoc, difference from t= 40). D Transient bouts of LA (preceded and followed by inactivity) caused a
significant response in RR and QT interval lengths, but not PRseg (two-way RM ANOVA, Dunnet’s post hoc, difference from t=−5). E Acute change in RR
(across 5-min analysis bins) was mirrored by concordant changes in QT, but not PRseg. F Representative body temperature profile recorded across a 9-h
advance of the LD cycle (data are double plotted; shaded regions indicate periods of darkness). G The 9-h phase advance led to profound separation in RR
(black) and PRseg (orange) interval rhythms. H Mean RR and PRseg intervals measured across dark (green) and light (pink) phases the day prior to shift
(day 0) and equivalent times on the day of the shift (day 1; two-way RM ANOVA, n= 11 mice). I Misalignment of RR and PRseg rhythms in response to the
shift in LD cycles disrupts the normal temporal relationship of the two parameters. Data reflect group mean PRseg/RR on the day prior to shift (black) and
the shift day (blue). All data presented as mean ± SEM. ns P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001. Source data and statistical details are provided as a
Source Data File.
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genes, progress rapidly to bidirectional ventricular tachycardia
(BVT). In line with these reports, we found that daytime (ZT0)
administration of caffeine and adrenaline to conscious free-
moving control mice resulted in only one of six animals tested
progressing to BVT (Fig. 6A, B). Remarkably, however,
catecholamine challenge at the start of the animals’ active phase
(ZT12) elicited BVT in all mice tested (six of six). This reveals a
previously unrecognized and profound effect of time of day on
arrhythmia propensity in vivo. We then challenged the
αMHCCREBmal1Fl/Fl mice at this vulnerable phase (ZT12) and
found an attenuated response, with only two of five mice showing
BVT (Fig. 6B and Supplementary Fig. 7A).
It is likely that increased vulnerability to catecholamine-
induced VT is associated with increased cardiomyocyte excit-
ability at night. To define potential mechanisms underlying both
the diurnal rhythms in arrhythmogenesis and the relative
protection obtained from cardiomyocyte-specific Bmal1 deletion,
we profiled ventricular gene expression in control and αMHC-
CREBmal1Fl/Fl mice at ZT0 and ZT12 (Supplementary Fig. 7B).
Differential gene expression revealed a number of candidate ion
channels and other factors (e.g., connexins) that have been linked
to ventricular arrhythmia. Across both time of day and genotype,
genes linked to intracellular calcium handling were particularly
evident, including significantly increased expression of Casq2 and
decreased expression of Ryr2 and Cacna1c (CaV1.2 subunit of the
L-type calcium channel) in αMHCCREBmal1Fl/Fl animals, relative
to control mouse hearts. These clock-directed changes in calcium
handling are likely to underpin the relative sensitivity to
induced arrhythmias and highlight a potential avenue for future
therapeutic intervention.
Discussion
These findings provide a critical understanding of how circadian,
autonomic, and behavioral inputs interact to determine the
temporal dynamics of cardiac electrophysiology and time-of-day
susceptibility to arrhythmia. We reveal a functional segregation of
acute (e.g., reflective of activity and/or sleep state) and circadian
inputs from the autonomic nervous system and local
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Fig. 4 Relative contribution of autonomic nervous system input and local cardiac clock in setting RR and PRseg in mice. A Heart rate variability (HRV)
during autonomic blockade (with metoprolol and atropine) in conscious free-moving mice (left panel: a geometric measure of HRV, shaded region
represents+ /− SEM, right panels: Poincaré plots pre-blockade (baseline, bl) and under complete block). B Complete autonomic blockade (met+ atr)
reduced, but did not remove, time-of-day-dependent differences in RR or QT intervals (blue: ZT0; black: ZT12; n= 8 mice). In contrast, no time-of-day
difference was observed in PRseg under complete autonomic blockade (two-way RM ANOVA, Sidak’s post hoc). C In contrast to Bmal1Fl/Fl control mice, no
time-of- day differences in RR or QT intervals were evident in αMHCCREBmal1Fl/Fl mice following complete autonomic blockade (n= 7 BmalFl/Fl, 9
aMHCcreBmalFl/Fl; two-way RM ANOVA, Sidak’s post hoc). D Twenty-four hours distribution of RR intervals in control (Bmal1Fl/Fl; top) and littermate
cardiomyocyte-specific Bmal1 knockout mice (αMHCCREBmal1Fl/Fl; bottom). Heatmap shows the occurrence of RR interval distribution across 5 days of
recording; black line reflects group mean. Substantial RR interval lengthening and variability were evident in the day and late-night. All data presented as
mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 between time, #P < 0.05 between treatment. See Supplementary Fig. S8 for additional information related
to this figure. Source data and statistical details are provided as a Source Data File.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22788-8 ARTICLE
NATURE COMMUNICATIONS | (2021) 12:2472 | https://doi.org/10.1038/s41467-021-22788-8 | www.nature.com/naturecommunications 7
cardiomyocyte clock influences over SA and AV nodal activity.
This segregated input reduces coordination within the conduction
system in response to acute shifts in the timing of the behavioral
routine. Importantly, these findings appear robust across both
human and mouse physiology. Our work also reinforces the
importance of daily rhythms in parasympathetic tone in shaping
circadian variation in HR and HRV and extends this to include a
profound influence over rhythms in AV node conduction. There
is evidence that vagal innervation of the SA and AV nodes can be
segregated at the level of the cardiac ganglion and medulla
nuclei28,29, and our findings suggest that these pathways may also
differentially deliver circadian input (Supplementary Fig. 8).
Indeed, the multisynaptic autonomic connection from the master
SCN clock to the heart has been demonstrated5, and we have
recently shown that the activity of VIP-expressing SCN neurons
can influence HR in a time-of-day-dependent manner30.
An influence of the local circadian clock on cardiac function is
already established in rodent models, with the cardiomyocyte
clock exerting rhythmic regulation over ~10% of the heart
transcriptome7,31,32. We extend these findings to the SA node,
where the inherent time-of-day-dependent rhythms in sinus node
pacing were evident in vivo, under complete autonomic blockade,
and in isolated hearts. We also show circadian clock function and
rhythmic expression of influential ion channels within the SA
node, providing a mechanism for daily rhythms in inherent HR.
These findings are in line with previous work showing an
important influence of the heart clock on heart contractility,







































































































































Fig. 5 A local heart clock drives time-of-day-dependent rhythms in cardiomyocyte excitability. A Representative recordings of spontaneous atrial (pink)
and ventricular (green) electrograms recorded in ex vivo Langendorff-perfused hearts collected from control (Bmal1Fl/Fl) and αMHCCREBmal1Fl/Fl mice at
ZT0 or ZT12. B Interbeat interval showed a time-of-day (ZT0 blue, ZT12 black) difference in control but not αMHCCREBmal1Fl/Fl hearts; A–V conduction
delay in isolated hearts did not vary by time of day (n= 7 hearts/group, two-way RM ANOVA, Sidak’s post hoc). C Representative multielectrode array
recording of spontaneous action potential firing in primary cardiomyocytes. D, E Spontaneous firing rate in isolated cardiomyocytes showed robust
circadian variation in constant culture conditions (D, n= 8, one-way RM ANOVA, Holm–Sidak post hoc), which followed rhythms of mPER2::LUC
bioluminescence recorded in parallel cultures (RLU: relative light units, E). F Representative ventricular traces and pacing protocol (stimulation train shown
below recording). Inset showing recovery to normal sinus rhythm (top) and induced ventricular tachycardia (VT; bottom). G Control hearts (n= 7/
timepoint) showed a significant time-of-day susceptibility to VT (ZT0: 2 of 7 hearts tested, ZT12: 6 of 7; Chi-square), whereas only 1 of 14
αMHCCREBmal1Fl/Fl hearts (n= 7/timepoint) were susceptible. All data presented as mean ± SEM. *P < 0.05, **P < 0.01. Source data and statistical details
are provided as a Source Data File.
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synthesis turnover1,33. Indeed, altered expression of cardiac ion
channels (e.g., Scn5a, Kcnh2) and some electrophysiological
measures (HR, QT interval) have been described in
cardiomyocyte-specific clock disrupted mice4,7,9,34,35. Here, we
also show explicitly that the cardiomyocyte clock dictates tem-
poral rhythms in cell excitability and susceptibility to ventricular
arrhythmia.
Previous studies have shown that wild-type mice are relatively
resistant to catecholamine-induced arrhythmias26,27. This is in
line with our results from the animals’ rest phase. However, a
dramatic increase in progression to BVT was observed at night,
similar to that previously ascribed to responses observed in sus-
ceptible transgenic mouse lines. Significant evidence in animals
and humans has shown that disturbances in intracellular calcium
handling can increase susceptibility to VT. In response to myo-
cyte depolarization, L-type calcium channels activate and pro-
mote calcium influx into the cytoplasm. This calcium influx
activates RYR2 on the sarcoplasmic reticulum (SR), leading to a
further substantial release of calcium ions from the SR, which in
turn activates myofilament activation and initiates contraction.
CASQ2 serves to bind calcium ions within the SR, thereby lim-
iting this intracellular calcium release. Reduction in CASQ2 levels
and/or mutations of Casq2 can cause arrhythmogenic calcium
release, leading to premature ventricular contractions and
arrhythmia. Conversely, overexpression of Casq2 can have a
protective effect due to increased calcium retention36,37. In hearts
lacking Bmal1 expression in cardiomyocytes, we found down-
regulation of Cacna1c and Ryr2, and marked upregulation of
Casq2. Thus, a decreased propensity to intracellular calcium
overload likely underlies the relative protection afforded by the
cardiomyocyte deletion of Bmal1.
The cardiomyocyte clock has previously been linked to cardiac
arrhythmias. For example, the genetic deletion or overexpression
of the transcriptional regulator KLF15 in mice can lead to
abnormal cardiac repolarization and enhanced susceptibility to
ventricular arrhythmias10. KLF15 is regulated by Bmal1 in the
heart, suggesting that clock-controlled rhythmicity in its expres-
sion could contribute to time-of-day variation in arrhythmo-
genesis. We find a robust time-of-day difference in Klf15
expression in ventricular tissue of control animals and significant
downregulation in cardiomyocyte-specific Bmal1 knockouts. In
addition, we identify rhythms in the expression of genes from a
range of potential systems that have been linked to ventricular
arrhythmias in human and mouse studies, including Calm2,
Kcnh2, Scn5a, Cx43, and Cx4538–42. While it is unlikely that any
one of these gene changes alone is driving the temporal pattern of
arrhythmias, our data suggest a generally more excitable
state within the ventricle at ZT12, driven in part by the
cardiomyocyte clock.
We believe that there are additional aspects of cellular rhyth-
micity, beyond oscillations in gene expression that contribute to
cardiomyocyte electrical state. Our recent work has revealed a
fundamental role for daily oscillations in cytosolic protein con-
centration and temporal variation in K+ and Na+ gradients in
dictating cardiomyocyte electrical state across the day43. This
work suggests that cardiomyocyte clock organization of the daily
timing of mTORC activity and macromolecular crowding drives a
concurrent oscillation in cytosolic ion concentration, which
imparts cell-intrinsic daily variation to firing frequency. Indeed,
increased mTOR expression and elevated protein synthesis have
been reported in cardiac Bmal1 knockout mice44, supporting the
view that alterations in overall protein synthesis contribute to the
electrophysiological phenotype in our mice.
It is clear that long-term shift work is associated with an ele-
vated risk of cardiovascular disease, the incidence of cardiac
events, and altered electrophysiological parameters15,45–48.
Whether alteration of cardiac conduction parameters during
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Fig. 6 In vivo propensity for catecholamine-induced bidirectional VT displays diurnal rhythmicity. A Typical ECG traces before (baseline) and after
injection of caffeine and adrenaline. Animals displayed rapid tachycardia, typically followed by bradycardia and sinus pauses and/or premature complexes,
with some progressing into bidirectional VT (bottom right). Vertical scale bars represent 0.5 mV and inset times are time from returning to the cage after
injection. B Proportion of animals that display evidence of each stage of VT progression. At ZT12, all control animals (six of six mice tested) displayed
robust evidence of bidirectional VT, compared to only one of six mice tested at ZT0. Only two of five αMHCCREBmal1Fl/Fl mice displayed bidirectional VT at
ZT12. *P < 0.05, **P < 0.01, Chi-square. Source data and statistical details are provided as a Source Data File.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22788-8 ARTICLE
NATURE COMMUNICATIONS | (2021) 12:2472 | https://doi.org/10.1038/s41467-021-22788-8 | www.nature.com/naturecommunications 9
arrhythmia or other harmful cardiac events in otherwise healthy
humans is not yet clear. Nevertheless, it is likely to be of
important clinical consideration in patients with pre-existing
cardiac dysfunction or injury, as well as in relation to ECG-based
diagnoses and pharmacological intervention, where the time of
day, patient occupation, and/or sleep–wake history may sig-
nificantly impact the outcome. Moreover, we show that suscept-
ibility to VT was rarely observed upon cardiomyocyte Bmal1
deletion, indicating that the circadian clock drives increased
excitability during the active period of the day at the cost of
creating vulnerability to arrhythmias. This suggests that clock
function within the heart contributes to the long-known temporal
variation in cardiac arrhythmia propensity observed in humans.
Given the widespread influence of the circadian clock and
established detrimental consequences of clock disruption, any
clock-directed intervention must be approached with caution.
Nevertheless, our findings offer an important and logical new
avenue for therapeutic investigation.
Methods
Human laboratory studies
Ethics. The human research studies complied with all the current ethical require-
ments and guidelines of the University of Surrey and Washington State University,
and conformed with the Declaration of Helsinki (2004), the Universal Declaration
of Human Rights and Covenants on Human Rights (UN General Assembly,
December 1948) and Data Protection Act, 1998. Study protocols were approved by
their respective ethics committees at the University of Surrey and Washington State
University and complied with all aforementioned ethical regulations. Participants
gave written, informed consent and met predefined inclusion criteria20,21.
Study one. Full details of this study are described in refs. 20,49. Briefly, 11 long-term
shift workers (males, aged 25–45 years) with a shift-work history of >5 years and 14
control participants (males, aged 25–42 years) were asked to keep a regular 7.5–8-h
sleep period prior to the laboratory session. During the laboratory session,
volunteers were kept in tightly controlled conditions for 4 days with self-selected
sleep durations of 7.5–8 h and wake times ranging from 5:30 to 8:00 h. All analyses
were done relative to the participants’ wake time. After a day of adaptation and
baseline recording, participants were kept awake for 30.5 h and allowed a sub-
sequent 4-h recovery nap (Fig. 1A). This was followed by a normal recovery day.
On control days (1, 2, and 4), subjects were posture fixed in a semi-recumbent
position for the same 4 h window as the nap on day 3. The light was fixed at a dim
~8 lux throughout wake periods and 0 lux during sleep periods. ECG was recorded
at 256 Hz throughout using a wireless polysomnographic system (Siesta EEG/PSG
recorder, Compumedics Ltd, Australia) via electrodes in two positions (right
midclavicular and around 6 cm under the left armpit) using ProFusion PSG2
(version 2.1, Compumedics Ltd). Data were converted to the European data format
for further analysis.
Study two. Full details of this study are described in refs. 12,21. Briefly, 14 partici-
pants (10 men, 4 women, aged 22–34 years) were randomly assigned to either the
“day” or “night” shift conditions. Prior to the laboratory session, participants
maintained a self-selected regular sleep schedule. During the laboratory session,
participants had fixed, 8-h windows of sleep opportunity. Both groups had 1 day of
baseline recording with sleep between 22:00 and 06:00 h before the “night shift”
group were, after a transition nap between 14:00 and 18:00 h, shifted to a 3-day
period with a sleep window between 10:00 and 18:00 h. This was followed by a day
in constant routine and a final recovery day. Lights were kept below 50 lux during
wakefulness. ECG was recorded at 4 kHz throughout except for an ~8-h window on
the 3rd day using a Holter monitor (DMS 300-3 A; Bravo, Huntington Beach, CA,
USA) with standard 5-lead electrode placement. Data were downsampled to
128 Hz for analysis.
Pre-study conditions for both human studies. Participants were free of any medical
conditions and not currently on medication known to affect cardiovascular,
metabolic, gastrointestinal, or immune function (including over-the-counter
medication). Participants did not suffer from sleep, depression, or anxiety disorders
as confirmed by self-reported pre-study questionnaires (both studies), history,
physical exam, and baseline polysomnography (study 2). All participants were
nonsmokers at the time of the study and had no history of alcohol abuse. All
participants had not been involved in shift work in the previous 3 months and had
not traveled across time zones in the previous month. A urine screen confirmed all
subjects were negative for drugs of abuse at the time of recruitment and during the
study. Participants were asked to refrain from heavy exercise (2 days prior to study
1), and substances including alcohol and caffeine (2 days prior to study 1, 1 week
prior to study 2).
Animals. All animal experiments were licensed under the Animals (Scientific
Procedures) Act of 1986 (UK) and were approved by the animal welfare com-
mittees at the University of Manchester and Laboratory of Molecular Biology,
Cambridge. C57BL6J mice were purchased from Charles River (UK) and other
mouse lines (αMHC:cre50, Bmal1f/f51, αMHC:cre+/−Bmal1f/f) were bred at the
University of Manchester. Mice imported from external breeders were acclimatized
to the local animal unit for at least 7 days prior to use. Mice were housed under a
12:12 h light/dark cycle at ~400 lux during the light phase and 0 lux during the dark
phase. Ambient temperature was kept at 22 ± 2 °C, the humidity was ~52 ± 7%,
with food and water available ad libitum. Mice were group-housed until the start of
ECG recording, during which they were individually housed and kept in light-tight
cabinets. Male and female mice (10–16 weeks of age, ~1:1 ratio) were used unless
stated otherwise.
ECG telemetry implantation. Mice were implanted with ETA-F20 telemetry devices
(Data Sciences International, USA) for the recording of body temperature, loco-
motor activity, and electrocardiography. Mice were anesthetized with isoflurane
(2–5% in oxygen, total duration ~20 min), following which the telemetry remote
was inserted into the abdominal cavity. Biopotential leads were secured ~1 cm right
of midline at upper chest level (negative) and ~1 cm left of the midline at the
xiphoid plexus (positive). Mice were allowed a recovery period of 7–10 days before
individual housing and the start of the experiment. For long-term recording body
temperature, locomotor activity, and a 10 s ECG sweep were recorded every 5 min.
For autonomic blockade studies, ECG was recorded continuously.
ECG analysis. All ECG analysis was done using bespoke ECG analysis software
written in MATLAB (R2018a; Mathworks, USA)11. Briefly, sweeps of 10,000 data
points were taken, corresponding to 10 s in mice and ~39/~78 s in humans (ana-
lyzed at 256/128 Hz), and R waves detected by amplitude thresholding and sub-
sequent template matching to the mean beat waveform of that sweep. Any
waveforms that differed significantly from that template were removed. Individual
recording sweeps were excluded from subsequent analysis where the mean
amplitude of discriminated beat waveforms was <3 times the lower limit of the
amplitude window, where baseline variation in the ECG trace exceeds 1/3 of that
lower limit and/or where >20% of the events detected were excluded by the tem-
plate matching algorithm.
For each valid beat, ECG features were automatically detected. The P wave was
identified as the maximal point between the previous beat and the current R wave.
P offset was set as the first positive deflection to the right of P peak in mice, and as
the point at which the ECG crossed the isoelectric line in humans. Q onset was set
as the first positive deflection to the left of R peak in mice, and the first negative
deflection to the left of that positive deflection in humans. T peak was identified as
the maximum (in humans) or minimum (in mice) point between the current R
wave and next P wave. T offset was set as the point at which the ECG returns to the
isoelectric line after T peak in mice, or as the first positive deflection after crossing
the isoelectric line in humans, dependent on T wave morphology.
ECG parameters were then calculated for each valid beat in the sweep and the
median was taken for the sweep. HR was calculated directly from the inverse of the
RR interval for each sweep. Importantly, there was no day/night bias to the number
of sweeps failing quality control, and adjustment of the quality control parameters
had little impact on the overall results. Human ECG data were subsequently binned
into 5-min bins for longitudinal analysis. In study 1, QT was not measured for four
individuals (two in the control group, two in shift-work group) as the end of the T
wave could not be reliably determined.
Random sweeps from each individual were visually inspected for accuracy of
automated feature detection and measurement. To validate the algorithm further,
we compared automatically detected PR, QT, and RR intervals of a representative
sweep from control individuals with manual measurements provided by an
experienced cardiologist (LAV) of the average of that sweep and found no
significant differences (Supplementary Fig S1C).
Common measures of HRV have limitations. Time-domain methods, such as
RR interval standard deviation (SDNN), are heavily influenced by absolute and
overall changes in HR. Frequency-domain measures require interpolation from
clean, stable ECGs from stationary participants, making them unsuitable for
continuous, long-term ECG analysis. For these reasons, we employed a simple,
robust geometric method based on relative RR intervals which is insensitive to
outliers and changes in absolute HR22.
Autonomic blockade. Conscious free-moving mice were injected with metoprolol
(10 mg/kg, i.p., Sigma-Aldrich, UK) to achieve sympathetic autonomic blockade. In
order to achieve total autonomic blockade, atropine (4 mg/kg, i.p., Sigma-Aldrich,
UK) was given 40–60 min after metoprolol. These times were chosen based on
when HR reaches a plateau following metoprolol injection. The total blockade was
marked by a stable attenuation in HRV, with analyses conducted over the following
30 min.
In vivo arrhythmia induction. Mice were implanted with telemetry devices (as
above) and allowed to recover for 10 days post surgery. At ZT0 or ZT12 on the day
of study, age-matched male mice were injected with 120 mg/kg caffeine (Fisher
Scientific, USA) and 2 mg/kg adrenaline (Sigma, US) in PBS. Animals were
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monitored for 15 min before culling. Trains of at least four alternating ventricular
premature complexes (characterized by a widening of QRS complexes and QRS
inversion) were identified as bidirectional VT. In most cases, they lasted >30 s.
Langendorff heart electrophysiology. Hearts were rapidly removed and placed into
ice-cold Krebs–Henseleit Buffer (KHB) solution (constituents in mM: 118 NaCl, 11
glucose, 1.8 CaCl2, 4.7 KCl, 25 NaHCO3, 1.2 MgSO4, 1.2 KH2PO4). Excess tissue
was removed, aorta cannulated under a dissection microscope and heart perfused
with KHB. Successful perfusion was confirmed when all visible vessels in the heart
cleared with perfusate. The cannulated heart was then attached to a heated glass
coil filled with oxygenated KHB and perfused at 37 °C at 4 ml/min. This whole
process took ~3–4 min. Hearts were then left to stabilize for 10 min; any hearts that
did not stabilize within this window were excluded (<10%). Monophasic action
potentials were recorded from the left atrial appendage and ventricular myo-
cardium using custom-made silver chloride electrodes, amplified using Bio-
amplifiers, digitized by Powerlab (4/35), and analyzed in LabChart (v8; ADIn-
struments, UK). Electrical stimulation was applied via a custom-made silver
chloride electrode to the ventricular myocardium. Electrode placement was con-
sistent between hearts and based on anatomical landmarks. Ventricular arrhyth-
mias were induced using an established protocol52 and ventricular tachycardia
(VT) was characterized according to the Lambeth convention53. Briefly, an S1 train
consisting of 20 pulses at 100-ms cycle length was immediately followed by S2–S10
train of extra stimuli. Extrastimuli cycle lengths ranged from 90 down to 18 ms,
decreasing in 3 ms intervals. Each segment of stimulation was separated by 2 s. VT
was defined as a train of at least four consecutive ventricular premature beats
following this stimulation. This process was repeated twice and hearts that dis-
played evidence of VT on both trials were classified as susceptible to VT. Animals
were culled between ZT 0–1 and ZT 11–12.
Cardiomyocyte isolation and recording. Primary cardiomyocytes were isolated from
P2-3 neonatal mice using a commercially available dissociation kit (130-098-373,
Miltenyi Biotec, Germany). Briefly, hearts were removed and cut into small sec-
tions in ice-cold dissociation buffer (constituents in mM: 106 NaCl, 20 HEPES, 0.8
NaH2PO4, 5.3 KCl, 0.4 MgS04, 5 glucose). Following enzymatic digestion, the
solution was filtered through a 70-μm filter and placed in dishes for 2 h. The
cardiomyocyte-containing supernatant was collected and 1 × 105 cardiomyocytes
were seeded onto the center of a multielectrode array (MEA) coated with 10 μg/ml
fibronectin (Sigma). After 5 h, DMEM high glucose media (supplemented with
17% M199 (ThermoFisher, USA), 10% horse serum, 5% newborn calf serum,
Glutamax, Pen/Strep, and Mycozap (Lonza)) was added. Media was then changed
daily for 8 days before a final media change and release into constant 37 °C con-
ditions. Every 12-h field potentials were recorded from the MEA using a MEA
recording device (MEA2100-2 × 60-system, MCS) for 5 mins at 20 kHz following a
2-min equilibration period. The recording was done at 37 °C, at atmospheric
conditions in a medium supplemented with 10 mM HEPES. Data were recorded
and analyzed using the Multi-Channel experimenter and DataManager software.
Data are presented from a single MEA (and replicated across different MEAs).
Cardiomyocyte bioluminescence was captured using ALLIGATORs (Cairn
Research) for 29 mins at 30 min intervals in constant, 37 °C conditions. Data were
detrended by subtraction of the 24 h moving average.
Gene expression analysis. For SA node dissection, male C57B6J mice (12 weeks of
age) were housed under a stable 12 h:12 h LD cycle for >10 days prior to dis-
section. SA nodal tissue was quickly microdissected and snap-frozen at six equal
time points across 24 h. For ventricular gene expression analyses, control
(Bmal1fl/fl) and αMHC:cre+/−Bmal1f/f mice were sacrificed at ZT0 or ZT12. In
all cases, tissue was homogenized (Bead mill 24; Fisherbrand), and total RNA
extracted using columns according to the manufacturer’s protocol (Reliaprep
tissue; Promega). cDNA was synthesized using High capacity RNA to cDNA kit
(Applied Biosystems). Quantitative PCR was performed on a 384 well thermal
cycler (7900; Applied Biosystems) using GoTaq Master Mix (Promega). Relative
gene expression was calculated using the ΔΔCt method using Hprt, Ppib, and
Actb as housekeeping genes. Primer sequences are listed as Supplementary
Material (Supplementary Table S3).
Data processing and analysis. Experimental design and n number determination
were based on appropriate power analysis and previous experience. All ECG data
were processed in MATLAB (R2018a; Mathworks, USA) using custom-written
algorithms as described below. In both human studies, data were z-scored across
the full laboratory session for each individual for analysis to normalize inter-
individual variability. For mouse studies, data were z-scored across the whole
analysis window (5 days for most analyses, ~9 days for phase shift experiments).
Phase delays between RR and other ECG parameters were calculated by comparing
the mean of a Gaussian fit to the cross correlogram in each individual to 0 using a
one-sample T test. To calculate the dependency of ECG parameters on HR, change
in z-scored RR between sequential 5 min ECG analysis windows were determined
and segregated into bins reflecting response magnitude (width 0.25 SD in humans,
0.5 SD in mice). Corresponding changes in QT and PRseg were averaged and
plotted against ΔRR interval. To determine the effects of locomotor activity on
ECG parameters a circadian profile of each parameter at rest was calculated for
each animal by fitting a 24-h constrained sine wave to all data points in which the
animal had not been active in the preceding 30 min over 5 days of normal
recording. Periods in which bouts of locomotor activity were followed by 45 min of
inactivity were then isolated and normalized to the appropriate circadian phase
based on the at-rest curve fit. The transient activity was identified as an activity
bout preceded by >5 min of inactivity and followed by >20 min of inactivity. Data
were normalized to the preceding 5 min of inactivity. RR interval distribution
heatmaps were calculated by binning RR intervals of mice across 5 days of
ECG recording into square bins of size 15 min × ~1.5 ms. Data were converted to
a probability of an RR interval falling into any given bin within each 15 min
window. Heatmaps were then filtered using a 5 SD Gaussian window with circular
padding.
Statistics and reproducibility. Statistics analyses were done in Prism (v8; Graphpad,
USA) using statistical tests described in figure legends. All statistical comparisons
were two-sided and exact P values test statistics are provided in a Source Data file.
Figures were compiled in CorelDraw (2018; Corel Corporation, Canada). The
experimental design of in vivo animal studies was based on power analyses and
previous experience. These studies were therefore not directly repeated; never-
theless, many findings were confirmed in independent studies (e.g., time-of-day
response in ECG parameter under autonomic blockade) involving wild-type and
transgenic mouse lines. In all studies, the reported n number reflects independent
biological replicates (i.e., human, mouse).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The materials used and datasets generated during this study are available from the
corresponding author on reasonable request. Raw ECG recordings have not been
included in the Source data file and are available from the corresponding author on
reasonable request. Source data are provided with this paper.
Code availability
The ECG analysis code used in this study is available in the GitHub repository (https://
github.com/EdHayter/Hayter-et-al.-ECG-analysis)54.
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